DaVita HealthCare Partners Inc. (DVA) experienced a significant surge of 14.52% in after-hours trading on Monday. The sharp upward movement followed the release of the company's fourth-quarter financial results and optimistic outlook for the coming year.

The dialysis services provider reported adjusted earnings per share of $3.40 for Q4 2025, surpassing analyst estimates. Revenue for the quarter reached $3.62 billion, also exceeding expectations. More importantly, DaVita provided 2026 adjusted EPS guidance in the range of $13.60 to $15.00, significantly above the consensus estimate, signaling management's confidence in future performance driven by steady demand for kidney dialysis services.

Additional factors contributing to positive sentiment include higher reimbursement rates, a favorable impact from flu vaccines, and the company's recovery from prior operational challenges. DaVita also announced a strategic investment in home care provider Elara Caring to co-develop a kidney-specific home-based care model, supporting its growth initiatives in personalized patient care.